NOTHING LIKE A CLASS ACTION FOR SLATER & GORDON TO MOVE ON

Written on the 29 April 2016 by Nick Nichols

NOTHING LIKE A CLASS ACTION FOR SLATER & GORDON TO MOVE ON

AFTER rankling shareholders with its own share price collapse late last year, listed legal group Slater & Gordon (ASX:SGH) has climbed back on the horse with plans to mount a class action of its own on behalf of Murray Goulburn investors.

Shares in Murray Goulburn slumped more than 40 per cent this week after the embattled milk supplier downgraded its FY16 profit forecast from $63 million to as low as $39 million.

It was the second downgrade by the company since it listed last year, with the company blaming lower dairy commodity prices and a slowdown in Chinese demand for infant formula.

The latest shock to investors led to the resignation this week of Murray Goulburn's CEO Gary Helou and CFO Brad Hingle.

Slater & Gordon, backed by litigation funder IMF Bentham, says it is investigating Murray Goulburn's profit guidance in its prospectus issued in July last year as a basis for the class action.

It says the potential class action will involve investors who bought units in Murray Goulburn's listed entity MG Unit Trust before April 27, including those who invested in the company's IPO in July last year.

Murray Goulburn had originally forecast a profit of $85.8 million for FY16, before downgrading that to $63 million on February 29, citing a downturn in dairy prices.

"On April 12, and again on April 18, Murray Goulburn confirmed that Chinese regulators were tightening regulations on imports of milk products into China, but denied that the anticipated regulatory changes would have a material impact on Murray Goulburn's business," says Slater & Gordon.

The legal firm is investigating whether Murray Goulburn misled investors with its initial prospectus forecast or with its downgraded profit forecast earlier this year. It also is investigating whether the company breached continuous disclosure obligations to investors.

"Our initial investigations have identified inconsistencies between Murray Goulburn's statements to the market regarding its likely profits in the 2016 financial year, and the factors that would affect its performance," says Slater & Gordon's senior class action lawyer Tim Finney.

"(Wednesday's) downgrade was of such a scale that it cannot be explained by the excuses that have so far been provided.

"We are investigating whether the true cause of Murray Goulburn's downgrade was an aggressively optimistic profit forecast, built into its product disclosure statement, that the company was simply never going to achieve."

Slater & Gordon's potential class action comes on the heels of the legal group enduring its own shareholder revolt late last year after it delivered a profit downgrade stemming from its trouble-plagued UK acquisition, Quindell.

Class action specialist Maurice Blackburn revealed it had received registrations from 'thousands of aggrieved shareholders' after Slater & Gordon's share price lost 90 per cent of its value over the past year.

In February, Slater & Gordon recorded a $958.3 million loss for the six months ending December last year, which included an $876.4 million impairment charge against goodwill and a $52.7 million impairment charge in the Australian business.

 


Author: Nick Nichols

Latest News

Q & A WITH FACEBOOK GURU ANDY MCKEON AS HE JOINS AUSTRALIAN SOFTWARE COMPANY LIVETILES

HE was creative director at Apple under the legendary Steve Jobs, and is now a senior Facebook executive. In his n...

EAST COAST PROPERTY BOOM BUILDS PROFITS FOR BRICKWORKS

AUSTRALIA'S residential property boom has helped drive a sharp rise in first half earnings for Brickworks (ASX: B...

COLLINS SUPERSIZES IN EUROPE WITH PURCHASE OF 16 KFC RESTAURANTS IN THE NETHERLANDS

COLLINS Foods (ASX:CKF) has stepped up its European expansion through the purchase of 16 KFC restaurants in the Ne...

CSIRO HELPS DEVELOP AUSTRALIAN PHARMA COMPANY FROM $10 MILLION TO $305 MILLION

GOVERNMENT backed scientists have helped multiply the market value of a previously small Australian pharmaceutical...

Related News

RAY OF HOPE FOR SLATER AND GORDON AS LENDERS STEP IN

EMBATTLED law firm Slater and Gordon (ASX: SGH) has announced to the ASX that it has launched confidential discussion...

SPROUTX PROVIDES THE SEED FOR AGTECH STARTUPS

AGTECH innovation fund SproutX has opened applications for its first accelerator round, backed by $10 million from...

GAS PRICES MAY FORCE BRICKWORKS TO TAKE MANUFACTURING OVERSEAS

BRICKWORKS Limited (ASX:BKW) chairman Robert Millner says soaring energy prices may force the company to turn to offs...

CHINA CONTINUES TO COLLECT AUSSIE PROPERTY ASSETS

CHINESE coin continues to dominate Australia's offshore real estate investment market, accounting for almost h...

EVENTS COMING UP

 

Contact us

Email News Update Sign Up Contact Details
Subscriptions

PO Box 2087
Brisbane QLD 4001

LoginTell a FriendSign Up to Newsletter